Published in J Eur Acad Dermatol Venereol on March 04, 2010
Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs (2014) 1.00
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study. Health Qual Life Outcomes (2013) 0.98
The costs of psoriasis medications. Dermatol Ther (Heidelb) (2013) 0.84
Family burden in inherited ichthyosis: creation of a specific questionnaire. Orphanet J Rare Dis (2013) 0.83
Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire. Health Qual Life Outcomes (2012) 0.78
How much of the productivity losses among psoriasis patients are due to psoriasis. BMC Health Serv Res (2015) 0.76
Effect of Oral PUVAsol on the Quality of Life in Indian Patients Having Chronic Plaque Psoriasis. Dermatol Res Pract (2014) 0.75
Influence of Psoriasis on Household Chores and Time Spent on Skin Care at Home: A Questionnaire Study. Dermatol Ther (Heidelb) (2015) 0.75
Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials. J Eur Acad Dermatol Venereol (2016) 0.75
Psoriasis causes significant economic burden to patients. Dermatol Ther (Heidelb) (2014) 0.75
Fatigue - an underestimated symptom in psoriatic arthritis. Reumatologia (2017) 0.75
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Chronic anal ulceration due to nicorandil. Br J Dermatol (2004) 3.18
First sexual intercourse: age, coercion, and later regrets reported by a birth cohort. BMJ (1998) 3.14
Complete amino acid sequence of the Mu heavy chain of a human IgM immunoglobulin. Science (1973) 2.97
Economic evaluation of pharmaceuticals: a European perspective. Pharmacoeconomics (1993) 2.96
Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort. BMJ (2000) 2.87
Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem (1999) 2.85
Oral contraceptives and fatal pulmonary embolism. Lancet (2000) 2.57
Folding patterns of porin and bacteriorhodopsin. EMBO J (1985) 2.34
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Current trends in the use of pharmacoeconomics and outcomes research in europe. Value Health (2006) 1.96
Sequence relationships of three human satellite DNAs. J Mol Biol (1986) 1.93
Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet (1995) 1.90
Waiting for elective surgery: effects on health-related quality of life. Int J Qual Health Care (1999) 1.90
Rab27a: A key to melanosome transport in human melanocytes. J Cell Biol (2001) 1.86
Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science (1986) 1.81
Enhanced tuberculosis identification through 1-month follow-up of smear-negative tuberculosis suspects. Int J Tuberc Lung Dis (2011) 1.79
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol (2001) 1.75
Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J (2000) 1.73
Mammographic screening: results from the 1996 National Breast Health Survey. Med J Aust (1997) 1.71
Roaccutane treatment guidelines: results of an international survey. Dermatology (1997) 1.70
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet (1994) 1.63
Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol (1998) 1.62
Dominant dystrophic epidermolysis bullosa associated with pyloric stenosis and congenital absence of skin. Arch Dermatol (2001) 1.60
Importance of the male factor in cancer of the cervix. Lancet (1982) 1.58
[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58
Complete development of hepatic stages of Plasmodium falciparum in vitro. Science (1985) 1.58
Epidemiology of pelvic ring injuries. Injury (1996) 1.58
Sample-specific ratio effects in matching to sample. J Exp Anal Behav (1983) 1.58
Giant oral aphthous ulcers induced by nicorandil. Br J Dermatol (1998) 1.58
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol (1996) 1.57
Arthritis, collagenous colitis, and discoid lupus. Ann Intern Med (1994) 1.52
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study. Br J Dermatol (2013) 1.50
Occurrence of AIDS in New Zealand: the first seven years. MRC AIDS Epidemiology Group. N Z Med J (1991) 1.48
Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones (2001) 1.47
Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis. Br J Dermatol (2011) 1.47
Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp Cell Res (1999) 1.47
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46
Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest (1996) 1.45
Oral contraceptives and breast cancer: a national study. Br Med J (Clin Res Ed) (1986) 1.44
Pregnancies among New Zealand teenagers: trends, current status and international comparisons. N Z Med J (2000) 1.44
Revisiting the enzymes stored in the laticifers of Carica papaya in the context of their possible participation in the plant defence mechanism. Cell Mol Life Sci (2001) 1.43
Patterns of disease and HIV testing at sexually transmitted disease clinics. N Z Med J (1997) 1.43
High-frequency ultrasonography but not 930-nm optical coherence tomography reliably evaluates melanoma thickness in vivo: a prospective validation study. Br J Dermatol (2014) 1.42
A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol (2002) 1.42
Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature (1970) 1.41
[Extracutaneous manifestations of neutrophilic dermatosis]. Ann Dermatol Venereol (1996) 1.41
EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol (1999) 1.41
Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia (2010) 1.41
Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem (1998) 1.40
[Atypical clinical forms of bullous pemphigoid]. Ann Dermatol Venereol (1990) 1.39
Oral contraceptives and venous thromboembolism continued. N Z Med J (2000) 1.39
[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39
[Benign desmoplastic fibroblastoma of the lower leg. A rare case]. Unfallchirurg (2004) 1.39
Malignant lymphoma and dermatitis herpetiformis. Dermatology (1994) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
Fibroblastic rheumatism: clinical, histological, immunohistological, ultrastructural and biochemical study of a case. Br J Dermatol (1993) 1.38
The extent of cervical screening in New Zealand women. N Z Med J (1991) 1.38
Factors associated with sun protection compliance: results from a nationwide cross-sectional evaluation of 2215 patients from a dermatological consultation. Br J Dermatol (2014) 1.38
[Practical use of antiseptics in dermatology]. Ann Dermatol Venereol (1989) 1.38
Incidence of cancer among Pacific Island people in New Zealand. N Z Med J (1993) 1.38
Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J Biol Chem (2000) 1.36
Transposable B2 SINE elements can provide mobile RNA polymerase II promoters. Nat Genet (2001) 1.35
Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res (1987) 1.34
Effects of maternal nutrition on the human fetus. Pediatrics (1973) 1.30
Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull World Health Organ (1990) 1.30
Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem (1996) 1.27
Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem (1995) 1.27
Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.26
Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship. Proc Natl Acad Sci U S A (2001) 1.25
The small heat shock proteins family: the long forgotten chaperones. Int J Biochem Cell Biol (2012) 1.23
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest (1991) 1.23
CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journals. Br J Dermatol (2009) 1.23
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol (2013) 1.22
Late presentation of HIV infection among adults in New Zealand: 2005-2010. HIV Med (2011) 1.21
Developmental expression of nicein adhesion protein (laminin-5) subunits suggests multiple morphogenic roles. Cell Adhes Commun (1994) 1.20
Congenital constriction band of the trunk. Pediatr Dermatol (1998) 1.19
The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J Cell Biol (2001) 1.19
Unlinked anonymous monitoring of HIV prevalence at sexually transmitted disease clinics. N Z Med J (1993) 1.19
Breast cancer screening adherence: does church attendance matter? Health Educ Behav (1998) 1.18
Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol (2005) 1.18
Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem (1996) 1.18
The 100-kDa chain of nicein/kalinin is a laminin B2 chain variant. Eur J Biochem (1994) 1.17
The lifetime occurrence of sexually transmitted diseases among a cohort aged 21. N Z Med J (1996) 1.17
A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet (1995) 1.17
The H3-H4 N-terminal tail domains are the primary mediators of transcription factor IIIA access to 5S DNA within a nucleosome. Mol Cell Biol (2000) 1.16
Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol (2004) 1.16
Inhibition of Rho is required for cAMP-induced melanoma cell differentiation. Mol Biol Cell (1998) 1.15
Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci U S A (1990) 1.15
Psoriasis: rationale for targeting interleukin-17. Br J Dermatol (2012) 1.14
Adoptive transfer of murine host protection to salmonellosis with T-cell growth factor-dependent, Salmonella-specific T-cell lines. Infect Immun (1985) 1.14
Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J Virol (1997) 1.14
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol (2010) 1.13
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.13
PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ (2004) 1.11